Professor of Antimicrobial Therapeutics at the University of Liverpool
Shampa Das (BSc, PhD) is a Professor of Antimicrobial Therapeutics at the University of Liverpool and PK/PD consultant. Following 17 years within the pharmaceutical industry, Shampa has extensive expertise in using PK-PD for developing Clinical Pharmacology and dose strategies to support the clinical development and regulatory approval of new anti-infective drugs. Her main research area is Antimicrobial Pharmacodynamics and Therapeutics with a focus on using PK-PD to inform critical decisions on adult and paediatric dosing. She is also PK-PD expert on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) steering committee for breakpoint decision.
